Botulinum toxin in facial rejuvenation
| LEADER | cam a22 4 4500 | ||
|---|---|---|---|
| 001 | 529010534 | ||
| 003 | CHVBK | ||
| 005 | 20201017113539.0 | ||
| 006 | m d | ||
| 007 | cr ||||||||||| | ||
| 008 | 180926s2004 xxka obf 001 0 eng | ||
| 015 | |a GBA3-U6024 |2 bnb | ||
| 020 | |a 978-0-7020-3802-0 | ||
| 020 | |a 978-0-7234-3349-1 | ||
| 020 | |a 0-7234-3349-6 | ||
| 035 | |a (NEBIS)007226863 | ||
| 035 | |a (SERSOL)ssj0000556362 | ||
| 035 | |a (OCoLC)324998731 |z (OCoLC)608354189 | ||
| 035 | |a (WaSeSS)ssj0000556362 | ||
| 040 | |a OPELS |d SzZuIDS NEBIS ETH-BIB | ||
| 050 | |a RC935.S64 |b M675 2004 | ||
| 060 | 0 | 0 | |a 2004 B-300 |
| 060 | 1 | 0 | |a WE 39 |b M854b 2004 |
| 082 | 0 | |a 615.373 |2 22 | |
| 245 | 0 | 0 | |a Botulinum toxin in facial rejuvenation |c Kate Coleman Moriarty |
| 260 | |a London |b Mosby |c 2004 | ||
| 300 | |a Online-Ressource | ||
| 504 | |a Includes bibliographical references (p. 143-146) and index. | ||
| 506 | |a Lizenzbedingungen können den Zugang einschränken. License restrictions may limit access. | ||
| 650 | 0 | |a Botulinum toxin |x Therapeutic use | |
| 650 | 0 | |a Facelift | |
| 650 | 2 | |a Botulinum Toxins, Type A |x therapeutic use |v Handbooks | |
| 650 | 7 | |a CLOSTRIDIENGIFTE, BOTULIN (TOXIKOLOGIE) |x ger |0 (ETHUDK)000040306 |2 ethudk | |
| 650 | 7 | |a HAUTMITTEL + DERMATOLOGISCHE ARZNEIMITTEL (PHARMAZIE) |x ger |0 (ETHUDK)000026724 |2 ethudk | |
| 650 | 7 | |a THERAPEUTISCHE PHARMAKOLOGIE, VERABREICHUNG VON ARZNEIMITTELN, CHEMOTHERAPIE, KLINISCHE PHARMAKOLOGIE |x ger |0 (ETHUDK)000026636 |2 ethudk | |
| 650 | 1 | 2 | |a Botulinum Toxins, Type A |x therapeutic use |0 https://id.nlm.nih.gov/mesh/D019274Q000627 |
| 650 | 1 | 2 | |a Face |0 https://id.nlm.nih.gov/mesh/D005145 |
| 650 | 2 | 2 | |a Cosmetic Techniques |0 https://id.nlm.nih.gov/mesh/D003357 |
| 650 | 2 | 2 | |a Injections, Intramuscular |0 https://id.nlm.nih.gov/mesh/D007273 |
| 650 | 2 | 2 | |a Patient Care Management |x methods |0 https://id.nlm.nih.gov/mesh/D010346Q000379 |
| 650 | 2 | 2 | |a Skin Aging |x drug effects |0 https://id.nlm.nih.gov/mesh/D015595Q000187 |
| 655 | 2 | |a Handbook |0 https://id.nlm.nih.gov/mesh/D020479 | |
| 691 | 7 | |B u |a CLOSTRIDIENGIFTE, BOTULIN (TOXIKOLOGIE) |z ger |u 615.915,798.521.3 |2 nebis E1 | |
| 691 | 7 | |B u |a THERAPEUTISCHE PHARMAKOLOGIE, VERABREICHUNG VON ARZNEIMITTELN, CHEMOTHERAPIE, KLINISCHE PHARMAKOLOGIE |z ger |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a HAUTMITTEL + DERMATOLOGISCHE ARZNEIMITTEL (PHARMAZIE) |z ger |u 615.262 |2 nebis E1 | |
| 691 | 7 | |B u |a TOXINES DE LA BACTÉRIE CLOSTRIDIUM, BOTULINE (TOXICOLOGIE) |z fre |u 615.915,798.521.3 |2 nebis E1 | |
| 691 | 7 | |B u |a POISONS OF CLOSTRIDIUM SPECIES, BOTULIN (TOXICOLOGY) |z eng |u 615.915,798.521.3 |2 nebis E1 | |
| 691 | 7 | |B u |a CLINICAL PHARMACOLOGY, THERAPEUTICAL PHARMACOLOGY, CHEMOTHERAPY, MEDICATION, ADMINISTRATION OF DRUGS |z eng |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a PHARMACOLOGIE THÉRAPEUTIQUE, APPLICATION DE MÉDICAMENTS, CHIMIOTHÉRAPIE, PHARMACOLOGIE CLINIQUE |z fre |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a MÉDICAMENTS DERMATOLOGIQUES (PHARMACIE) |z fre |u 615.262 |2 nebis E1 | |
| 691 | 7 | |B u |a SKIN DRUGS + DERMATOLOGICAL DRUGS (PHARMACY) |z eng |u 615.262 |2 nebis E1 | |
| 700 | 1 | |a Moriarty |D Kate Coleman | |
| 856 | |u http://sfx.ethz.ch/sfx_locater?sid=ALEPH:EBI01&genre=book&isbn=9780723433491 |z Online via SFX |3 Volltext | ||
| 898 | |a BK020053 |b XK020053 |c XK020000 | ||
| 909 | 7 | |a EText |2 nebis ED | |
| 909 | 7 | |a E01-Elsevier |2 nebis ER | |
| 909 | 7 | |a noalma |2 ids I | |
| 909 | 4 | |f eBook - Clinical Medicine 2000 - 2007 [EBCM0007] | |
| 909 | 4 | |a E-Books von 360MarcUpdates | |
| 912 | 7 | |a 134 |2 E01-20160215 | |
| 949 | |B NEBIS |F E01 |b E01 |c EL |j Online | ||
| 949 | |B IDSBB |F B405 |b B405 |c 405VT |x NELB4051809 | ||
| 950 | |B NEBIS |P 700 |E 1- |a Moriarty |D Kate Coleman | ||
| 950 | |B NEBIS |P 856 |E -- |u http://sfx.ethz.ch/sfx_locater?sid=ALEPH:EBI01&genre=book&isbn=9780723433491 |z Online via SFX |3 Volltext | ||
| 950 | |B IDSBB |P 100 |E 1- |a Moriarty |D Kate Coleman | ||
| 950 | |B IDSBB |P 856 |E 40 |u https://www.sciencedirect.com/science/book/9780723433491 |z Uni Bern: Volltext | ||